BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 8:54:00 AM | Browse: 862 | Download: 818
 |
Received |
|
2013-04-25 13:00 |
|
Peer-Review Started |
|
2013-04-25 21:50 |
|
To Make the First Decision |
|
2013-07-19 08:54 |
|
Return for Revision |
|
2013-07-20 22:49 |
 |
Revised |
|
|
|
Second Decision |
|
2013-08-20 12:08 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2013-08-20 13:34 |
|
Articles in Press |
|
|
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2013-11-08 17:01 |
|
Publish the Manuscript Online |
|
2013-11-11 15:30 |
| Category |
Virology |
| Manuscript Type |
Minireviews |
| Article Title |
Does prophylactic antidepressant treatment boost interferon-alpha treatment completion in HCV?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Paul J Rowan |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Paul J Rowan, PhD, MPH, Division of Management, Policy, and Community Health, University of Texas Health Sciences Center at Houston School of Public Health, 1200 Herman Pressler Drive, Houston, TX 77030, United States. prowan@uth.tmc.edu |
| Key Words |
Depression; Therapy; Clinical; Psychiatry |
| Core Tip |
To inform clinical practice, this narrative review summarizes existing evidence regarding the degree that antidepressant prophylaxis boosts hepatitis C antiviral treatment completion compared to a rescue approach. |
| Publish Date |
2013-11-11 15:30 |
| Citation |
Rowan PJ. Does prophylactic antidepressant treatment boost interferon-alpha treatment completion in HCV? World J Virol 2013; 2(4): 139-145 |
| URL |
http://www.wjgnet.com/2220-3249/full/v2/i4/139.htm |
| DOI |
http://dx.doi.org/10.5501/wjv.v2.i4.139 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
